Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
OverseasPhase FindingI SBIR
AusIndustryNational Institute for Allergy and Infectious Disease
AUDUSD$502,050300,000
2016-182020-21
https://www.business.gov.au/assistance/research-and-development-tax-incentive
Adrian Lievano
Bioengineer
Justin Jarrell, PhD
ScientistVice President, Research
KatherineBrandon LauSytsma
Bioengineer
Ryan Pawell
CEOFounder, Chief Executive Officer
Non-dilutive Funding
BioMedTech Horizons Precision Medicine
MTP Connect
AUD$891,500
2018-20
Medical Device Fund
NSW Health
AUD$500,000
2018
Minimum Viable Product
Jobs for NSW
AUD$15,000
2016
https://www.jobsfornsw.com.au/our-products/minimum-viable-product
Overseas Finding
AusIndustry
AUD$502,050
2016-18
https://www.business.gov.au/assistance/research-and-development-tax-incentive